Patent Foramen Ovale Clinical Trial
Official title:
PARADOX Trial: A Prospective, Double-Blind, Randomized Controlled Trial in Patients With Patent Foramen Ovale and Endocardial Device Leads on Apixaban for Prevention of Paradoxical Emboli
Patients with a patent foramen ovale in the setting of endocardially placed cardiac implantable electronic devices such as pacemakers, defibrillators, or resynchronization therapies are likely at higher risk for paradoxical embolic events from device lead thrombus. The investigators are conducting this study to determine if the anticoagulant medication Apixaban is more effective at reducing MRI detected brain lesions compared to placebo.
This is a prospective, double-blinded, placebo-controlled, randomized controlled trial (RCT).
400 patients who meet the study eligibility criteria and consent for enrollment will be
randomized in a 1:1 ratio to intervention with apixaban or control group with placebo. The
randomization will be performed by a computer generated block randomization protocol. The
majority of patients will begin intervention with Apixaban or placebo at the time of cardiac
device placement (n approximately 300), and at least a quarter of the randomized patients (n
≥100) will include preexisting CIED (≥6 months) in place. Each patient will undergo a
baseline MRI and a comprehensive cognitive screening examination. Repeat MRI and cognitive
assessment will be performed at a follow-up period of two years from date of randomization
(or less if clinical stroke/TIA occurs prior to this follow-up period). All subjects will
receive a phone call at 6 months, 12 months, and 18 months post-randomization to assess for
endpoints and adverse events, as well as changes in clinical status, medications, and to
assess study medication compliance.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06192173 -
Patent Foramen Ovale Closure in Migraine
|
||
Recruiting |
NCT04610463 -
Evaluation of the Severity of Right to Left Shunt in PFO Patients After Systemic Embolism
|
N/A | |
Completed |
NCT02882815 -
Post Market Clinical Follow-up Study of IrisFITTM PFO (Patent Foramen Ovale) Occluder
|
N/A | |
Completed |
NCT04604015 -
RoBotic TCD Ultrasound BubbLe Study Compared to Transthoracic Echocardiography for Detection of Right to Left Shunt
|
N/A | |
Active, not recruiting |
NCT04950192 -
Philips Intracardiac Echocardiography (ICE) Clinical Registry
|
||
Not yet recruiting |
NCT04549272 -
Assessment of Early Vascular Damage With Advanced Neuroimaging in Patient With Patent Foramen Ovale
|
||
Completed |
NCT02621528 -
Lifetech CeraFlex™ Post-Market Surveillance Study
|
N/A | |
Terminated |
NCT01018355 -
The Effect of Device Closure of Patent Foramen Ovale in Elderly Patients With Crytogenic Stoke/TCI
|
N/A | |
Completed |
NCT00831259 -
Risk of Stroke in Pulmonary Embolism With a Patent Foramen Ovale (PFO)
|
N/A | |
Not yet recruiting |
NCT05360771 -
Study on the Safety and Effectiveness of the SnowyTM PFO Closure System
|
N/A | |
Recruiting |
NCT05546320 -
Comparison of the Effect of Medication Therapy in Alleviating Migraine With Patent Foramen Ovale
|
Phase 4 | |
Recruiting |
NCT05561660 -
COMParison of the EffecT of dEvice Closure in Alleviating Migraine With PFO (COMPETE-2)
|
Phase 4 | |
Completed |
NCT03904277 -
Does Patent Foramen Ovale Size Matter in Men and Women
|
||
Recruiting |
NCT06120270 -
CeraFlex PFO Closure System PMCF Study
|
||
Terminated |
NCT01773252 -
Right to Left Cardiac Shunt Detection
|
Phase 3 | |
Completed |
NCT01216423 -
Pulmonary Embolism and Stroke in Patient With Patent Foramen Ovale
|
N/A | |
Completed |
NCT03377465 -
Biomarkers, Hemodynamic and Echocardiographic Predictors of Ischemic Strokes and Their Influence on the Course and Prognosis
|
N/A | |
Active, not recruiting |
NCT04738071 -
International Multicenter Patent foRamen OVale & strokE (IMPROVE) Registry
|
||
Not yet recruiting |
NCT06413147 -
Long-term Procedural and Device Related Complications of PFO Closure
|
||
Not yet recruiting |
NCT06344494 -
Cardiac Interventional ICE Imaging Trial
|
N/A |